MEANS FOR CORRECTION OF CHOLINERGIC DISORDERS OF THE MNESTIC PROCESSES

FIELD: pharmaceuticals.SUBSTANCE: invention relates to the pharmaceutical industry, namely to a means correcting cholinergic disorders of mnestic processes. Use of diterpene alkaloid songorine as a means of correcting the cholinergic disorders of mnestic processes.EFFECT: above-described agent is effective for correcting cholinergic disorders of mnestic processes.1 cl, 1 dwg, 4 tbl.

Medienart:

Patent

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Europäisches Patentamt - (2018) vom: 05. Sept. Zur Gesamtaufnahme - year:2018

Sprache:

Englisch

Beteiligte Personen:

NESTEROVA YULIYA VLADIMIROVNA [VerfasserIn]
POVETEVA TATYANA NIKOLAEVNA [VerfasserIn]
SUSLOV NIKOLAJ INNOKENTEVICH [VerfasserIn]
ZYUZKOV GLEB NIKOLAEVICH [VerfasserIn]
ZHDANOV VADIM VADIMOVICH [VerfasserIn]
FEDOROVA YULIYA SERGEEVNA [VerfasserIn]
KULPIN PAVEL VALEREVICH [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

615
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
Che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2018-09-05, Last update posted on www.tib.eu: 2022-05-31, Last updated: 2023-02-09

Patentnummer:

RU2665970

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA00968512X